Abstract
Several pilot studies have indicated that SLN biopsy can be used to identify axillary lymph node metastases in patients with breast cancer. To confirm this finding, a multicenter study in a variety of practice settings was performed. A total of 674 patients with breast cancer at five institutions were enrolled. The techniques of SLN identification included the vital dye-guided and the vital dye- and gamma probe-guided methods. The SLN was removed, and complete axillary lymph node dissection (ALND) was performed. SLN and ALND specimens were examined separately. The SLN was successfully identified in 214 (94%) of 227 patients using the combined dye- and gamma probe-guided methods. The SLN was identified in 332 (74%) of 447 patients using vital dye-guided method alone. Patient age of at least 51 years, medially located primary tumor, and clinically positive nodes were correlated with failure to identify the SLN. The accuracy of SLN biopsy for the detection of metastatic disease was 96% (522 of 546), and the sensitivity was 90% (203 of 226). Accuracy of 100% was achieved in the patients with tumors less than 1.6 cm in diameter. All 23 false negative results occurred with larger primary tumors. SLN biopsy can accurately predict the presence or absence of axillary lymph node metastases, particularly in patients with small (≤ 1.5 cm) breast cancers.
Similar content being viewed by others
References
Senofsky GM, Moffat FL Jr, Davis K, et al.: Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 126: 1336-1342, 1991
Fentiman IS, Mansel RE: The axilla: not a no-go zone. Lancet 337: 221-223, 1991
Noguchi M, Miwa K, Michigishi T, et al.: The role of axillary lymph node dissection in breast cancer management. Breast Cancer 4: 143-153, 1997
Fisher B, Redmond C, Fisher ER, et al.: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674-681, 1985
Lythgoe JP, Palmer MK: Manchester regional breast study - 5 and 10 years results. Br J Surg 69: 693-696, 1982
Cancer Research Campaign Work Party: Cancer Research Campaign (King's Cambridge) trial for early breast cancer. Lancet 2: 55-60, 1980
Kissin MW, Querci della Rovere G, Easton D, et al.: Risk of lymphedema following the treatment of breast cancer. Br J Surg 73: 580-585, 1986
Noguchi M, Katev N, Miyazaki I: Diagnosis of axillary lymph node metastases in patients with breast cancer. Breast Cancer Res Treat 40: 283-293, 1996
Krag DN, Weaver OJ, Alex JC, et al.: Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 2: 335-340, 1993
Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391-401, 1994
Albertini JA, Lyman GH, Cox C, et al.: Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. J Am Med Assoc 276: 1818-1822, 1996
Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 39: 456-466, 1997
Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127: 392-399, 1992
Alex JC, Krag DN: Gamma-probe guided localization of lymph nodes. Surg Oncol 2: 137-143, 1993
Turner RR, Ollila DW, Krasne DL, et al.: Histopathological validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226: 271-278, 1997
Veronesi U, Paganelli G, Galimberti V, et al.: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph node. Lancet 349: 1864-1867, 1997
Cody HS III: Sentinel lymph node mapping in breast cancer. Breast Cancer 6: 13-22, 1999
Japan Breast Cancer Society: General rules for clinical and pathological recording of breast cancer. 12th edition. Tokyo: Kanehara, 1996, pp 19-34
International Union Against Cancer (UICC): Breast tumors (ICD-0 C-50). In: Sobin LH and Wittekind Ch (eds) TNM Classification of Malignant Tumours, 5th edn, John Wiley & Sons, New York, 1997, pp 123-130.
Cox CE, Pendas S, Joseph E, et al.: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227: 645-653, 1998
Noguchi M, Tsugawa K, Kawahara F, et al.: Dye-guided sentinel lymphadenectomy in clinically node-negative and nodepositive breast cancer patients. Breast Cancer 5: 381-387, 1998
Motomura K, Inaji H, Komoike Y, et al.: Sentinel node biopsy in breast cancer with clinically negative lymph-nodes. Breast Cancer 6; 259-262, 1999
Imoto S, Hasebe T: Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East. Jpn J Clin Oncol 29: 11-15, 1999
Noguchi M, Bando E, Tsugawa K, et al.: Staging efficacy of breast cancer with sentinel lymphadenectomy. Breast Cancer Res Treat 57: 221-229, 1999
Sato K, Hiraide H, Uematsu M, et al.: Efficacy and significance of sentinel lymph node identification with technetium-99m-labeled tin colloids for breast cancer. Breast Cancer 5: 389-393, 1998
The World Health Organization: The World Health Organization histological typing of breast tumors. Am J Clin Pathol 78: 806-816, 1982
Giuliano AE: Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 62: 75-77, 1996
O'Hea BJ, Hill ADK, El-Shirbiny AM, et al.: Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186: 423-427, 1998
Cody HS III: Sentinel lymph node mapping in breast cancer. Breast Cancer 6: 13-22, 1999
Borgstein PJ, Pijpers R, Comans FF, et al.: Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lym phoscintigraphy and gamma probe detection. J Am Coll Surg 186: 275-283, 1998
Roumen RMH, Valkenburg JGM, Geuskens LM: Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23: 495-502, 1997
Pijpers R, Meijer S, Hoekstra OS, et al.: Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38: 366-368, 1997
Paganelli G, De Cicco C, Cremonesi M, et al.: Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 42: 49-53, 1998
Noguchi M, Tsugawa K, Bando E, et al.: Sentinel lymphadenectomy in breast cancer: identification of sentinel lymph node and detection of metastases. Breast Cancer Res Treat 53: 97-104, 1999
Strand SE, Persson BRR: Quantitative lymphoscintigraphy: basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 20: 1038-1046, 1979
Gulec SA, Moffat FL, Carroll RG, Krag DN: Gamma probe guided sentinel node biopsy in breast cancer. GJ Nucl Med 41: 251-261, 1997
Krag DN, Ashikaga T, Harlow SP, Weaver DL: Development of sentinel node targeting technique in breast cancer patients. Breast 4: 67-74, 1998
Harlow S, Krag D, Weaver D, Ashikaga T: Extra-axillary sentinel lymph nodes in breast cancer. Breast Cancer 6: 159-165, 1999
Giuliano AE, Dale PS, Turner RR, et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 394-401, 1995
Galimberti V, Zurrida S, Zucali P, Luini A: Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? Breast 7: 8-10, 1998
Viale G, Bosari S, Mazzarol G, et al.: Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85: 2433-2438, 1999
Offodile R, Hoh C, Barsky SH, et al.: Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabelled dextran. Cancer 82: 1704-1708, 1998
Krag D, Weaver D, Ashikaga T, et al.: The sentinel node in breast cancer. A multicenter validation study. New Engl J Med 339: 941-946, 1998
Noguchi M: Comment on 'Improved axillary staging of breast cancer with sentinel lymphadenectomy'. Ann Surg 225: 126-127, 1997
Veronesi U, Cascinelli N, Greco M, et al.: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202: 702-707, 1985
Noguchi M, Tsugawa K, Miwa K, et al.: Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol 73: 75-80, 2000
Veronesi U, Valagussa P: Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 47: 170-175, 1981
Kramer EL: Lymphoscintigraphy: radiopharmaceutical selection and methods. Nucl Med Biol 17: 57-63, 1990
Veronesi U, Zurrida S, Galimberti V: Consequences of sentinel node in clinical decision making in breast cancer and prospects for future studies. Eur J Surg Oncol 24: 93-95, 1998
Veronesi U: Sentinel-node biopsy in breast cancer. Lancet 350: 808-809, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Noguchi, M., Motomura, K., Imoto, S. et al. A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63, 31–40 (2000). https://doi.org/10.1023/A:1006428105579
Issue Date:
DOI: https://doi.org/10.1023/A:1006428105579